Skip to main content
SpringerLink
Log in

Decreased Expression of SOX7 is Correlated with Poor Prognosis in Lung Adenocarcinoma Patients

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Lung adenocarcinoma is the most frequently histologic subtype and the most histologically heterogeneous form of lung cancer. De-regulation of Wnt/β-catenin signaling pathway is implicated in lung carcinogenesis. SOX7, as a member of high mobility group (HMG) transcription factor family, plays a role in the modulation of the Wnt/β-catenin signaling pathway. However, the expression pattern and clinicopathological significance of SOX7 in patients with lung adenocarcinoma is still unclear. To address this problem, the SOX7 mRNA expression was detected by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Immunohistochemical studies were performed on 288 pairs of adjacent normal lung and lung adenocarcinoma tissues with complete follow-up records. Association of SOX7 protein expression with clinical outcomes was evaluated using the Kaplan-Meier method and a multivariate Cox proportional hazards regression model. SOX7 mRNA expression was significantly down-regulated in lung adenocarcinoma compared with matched adjacent normal tissues (P < 0.001). SOX7 protein was expressed in the cytoplasm of lung adenocarcinoma cells in 106/288 (36.8 %) of cases, whereas its immunoreactivities were predominantly located in the cytoplasm of the adjacent normal tissues. The reduced SOX7 expression was correlated with poor differentiation (P = 0.002), lymph node metastasis (P = 0.011) and advanced TNM stage (P = 0.006). Regarding patient survival, the overall survival and the disease-free survival rates were both significantly lower in patients with SOX7-negative tumors than in those with SOX7-positive tumors (P = 0.018 and 0.013, respectively). Multivariate analysis using a Cox proportional-hazards model demonstrated that SOX7 expression status was an independent prognostic factor predicting the overall survival and the disease-free survival of patients with lung adenocarcinoma (P = 0.021 and 0.016, respectively).Our data suggest that the decreased expression of SOX7 is an important feature of lung adenocarcinoma. The expression level of SOX protein may be a useful prognostic marker for patients with lung adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B (2011) Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients. Clin Lung Cancer 12:237–44

    Article  PubMed  CAS  Google Scholar 

  2. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization International Histological Classification of Tumours. Pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press, Lyon

    Google Scholar 

  3. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D (2011) International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–85

    Article  PubMed  Google Scholar 

  4. Katoh Y, Katoh M (2005) Comparative genomics on SOX2 orthologs. Oncol Rep 14:797–800

    PubMed  CAS  Google Scholar 

  5. Hosking BM, Wyeth JR, Pennisi DJ, Wang SC, Koopman P, Muscat GE (2001) Cloning and functional analysis of the Sry-related HMG box gene, Sox18. Gene 262:239–47

    Article  PubMed  CAS  Google Scholar 

  6. Herpers R, van de Kamp E, Duckers HJ (2008) Schulte-Merker: redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish. Circ Res 102:12–15

    Article  PubMed  CAS  Google Scholar 

  7. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F, Beltrame M (2008) Sox18 and Sox7 play redundant roles in vascular development. Blood 111:2657–66

    Article  PubMed  CAS  Google Scholar 

  8. Gandillet A, Serrano AG, Pearson S, Lie-A-Ling M, Lacaud G, Kouskoff V (2009) Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 114:4813–22

    Article  PubMed  CAS  Google Scholar 

  9. Katoh M (2002) Expression of human SOX7 in normal tissues and tumors. Int J Mol Med 9:363–8

    PubMed  CAS  Google Scholar 

  10. Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, Han Z, Wang X, Ren G, Su D, Huang B, Lu J (2009) SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277:29–37

    Article  PubMed  CAS  Google Scholar 

  11. Guo L, Zhong D, Lau S, Liu X, Dong XY, Sun X, Yang VW, Vertino PM, Moreno CS, Varma V, Dong JT, Zhou W (2008) Sox7 is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 6:1421–30

    Article  PubMed  CAS  Google Scholar 

  12. Gong YD, Dong MS, Lee SB, Kim N, Bae MS, Kang NS (2011) A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines. Bioorg Med Chem 19:5639–47

    Article  PubMed  CAS  Google Scholar 

  13. Pacheco-Pinedo EC, Durham AC, Stewart KM, Goss AM, Lu MM, Demayo FJ, Morrisey EE (2011) Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest 121:1935–45

    Article  PubMed  CAS  Google Scholar 

  14. Xu X, Sun PL, Li JZ, Jheon S, Lee CT, Chung JH (2011) Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. J Thorac Oncol 6:716–24

    Article  PubMed  Google Scholar 

  15. Teng Y, Wang X, Wang Y, Ma D (2010) Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392:373–9

    Article  PubMed  CAS  Google Scholar 

  16. Takash W, Cañizares J, Bonneaud N, Poulat F, Mattéi MG, Jay P, Berta P (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29:4274–83

    Article  PubMed  CAS  Google Scholar 

  17. Kormish JD, Sinner D, Zorn AM (2010) Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn 239:56–68

    PubMed  CAS  Google Scholar 

  18. Ding D, Xu H, Liang Q, Xu L, Zhao Y, Wang Y (2011) Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways. Int Orthop. In press

  19. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, Markowitz D, Reisfeld RA, Luo Y (2011) Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 104:1410–7

    Article  PubMed  CAS  Google Scholar 

  20. Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, Thijssen PE, Wirtz PW, Twijnstra A, Smitt PA, van der Maarel SM, Verschuuren JJ (2009) SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 27:4260–7

    Article  PubMed  CAS  Google Scholar 

  21. Vural B, Chen LC, Saip P, Chen YT, Ustuner Z, Gonen M, Simpson AJ, Old LJ, Ozbek U, Gure AO (2005) Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer 103:2575–83

    Article  PubMed  CAS  Google Scholar 

  22. Friedman RS, Bangur CS, Zasloff EJ, Fan L, Wang T, Watanabe Y, Kalos M (2004) Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J Immunol 172:3319–27

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Hepatobiliary and Enteric Surgery Research Center of Ministry of Health, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha, Hunan, China

    Bing Li, Boyun Huang & Yangde Zhang

  2. Department of Cardiology, the Third Affiliated Hospital of Inner Mongolia Medical College (Baogang Hospital of Inner Mongolia), Shaoxian Road 20, Kun District, Baotou, Inner Mongolia, China

    Bing Li & Zhiping Ge

  3. Department of Genery Surgery, the Third Affiliated Hospital of Inner Mongolia Medical College (Baogang Hospital of Inner Mongolia), Shaoxian Road 20, Kun District, Baotou, Inner Mongolia, China

    Shipeng Song & Shengbin Zhang

  4. Department of Cardiology, the second Affiliated Hospital of Baotou Medical College, Baotou, China

    Hong Yan

Authors
  1. Bing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhiping Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shipeng Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shengbin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hong Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Boyun Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yangde Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yangde Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, B., Ge, Z., Song, S. et al. Decreased Expression of SOX7 is Correlated with Poor Prognosis in Lung Adenocarcinoma Patients. Pathol. Oncol. Res. 18, 1039–1045 (2012). https://doi.org/10.1007/s12253-012-9542-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-012-9542-8

Keywords

Search

Navigation